Matches in SemOpenAlex for { <https://semopenalex.org/work/W3137669883> ?p ?o ?g. }
- W3137669883 endingPage "756" @default.
- W3137669883 startingPage "744" @default.
- W3137669883 abstract "•Recurrence of FMR is determined by LV dilation before MitraClip implantation.•In patients with FMR, a point of no return of MV tethering exists.•Remodeling after MitraClip placement is markedly different between FMR and OMR.•Recurrence of OMR after MitraClip implantation could not be predicted.•MV remodeling after MitraClip placement can be comprehensively analyzed by 3D echo. BackgroundMitraClip implantation has become the standard transcatheter mitral valve repair (TMVR) technique for severe mitral regurgitation (MR). However, approximately one third of patients have poor outcomes, with MR recurrence at follow-up. The aim of this study was to investigate whether quantitative analysis of mitral valve (MV) geometry on three-dimensional (3D) echocardiography can identify geometric parameters associated with the recurrence of severe functional MR (FMR) versus organic MR (OMR) at 6-month follow-up after TMVR using the MitraClip.MethodsSixty-one patients with severe FMR (n = 45) or OMR (n = 16) who underwent transesophageal 3D echocardiography before and 6 months after TMVR were retrospectively analyzed. MV geometry was quantified using 3D echocardiography software. Vena contracta area (VCA) at 6-month follow-up was used to define two outcome groups: patients with good results with VCA < 0.6 cm2 (MR < 0.6) and those with MR recurrence with VCA ≥ 0.6 cm2 (MR ≥ 0.6).ResultsMR recurrence was found in 34% of all study patients (21 of 61). In patients with FMR, significant differences between MR < 0.6 and MR ≥ 0.6 were found at baseline for tenting index (1.13 vs 1.23, P = .004), tenting volume (2.8 vs 4.0 ml, P = .04), indexed left ventricular (LV) end-diastolic volume (68.0 vs 99.9 ml/m2, P = .001), and VCA (0.71 vs 1.00 cm2, P = .003); no significant parameters of MR recurrence were found in patients with OMR. Multivariate analysis identified indexed LV end-diastolic volume as the strongest independent determinant of MR recurrence. Receiver operating characteristic analysis identified a tenting index of 1.185 (area under the curve 0.79) and indexed LV end-diastolic volume of 88 ml/m2 (area under the curve 0.76) to best discriminate between MR < 0.6 and MR ≥ 0.6.ConclusionsMR recurrence after TMVR in patients with FMR is associated with advanced LV dilation and MV tenting before TMVR, which provides clinical implications for a point of no return beyond which progressive LV dilation with MV geometry dilation and tethering cannot be effectively prevented by TMVR. In contrast, no significant determinants of MR recurrence and progressive MV annular dilation could be identified in patients with OMR. MitraClip implantation has become the standard transcatheter mitral valve repair (TMVR) technique for severe mitral regurgitation (MR). However, approximately one third of patients have poor outcomes, with MR recurrence at follow-up. The aim of this study was to investigate whether quantitative analysis of mitral valve (MV) geometry on three-dimensional (3D) echocardiography can identify geometric parameters associated with the recurrence of severe functional MR (FMR) versus organic MR (OMR) at 6-month follow-up after TMVR using the MitraClip. Sixty-one patients with severe FMR (n = 45) or OMR (n = 16) who underwent transesophageal 3D echocardiography before and 6 months after TMVR were retrospectively analyzed. MV geometry was quantified using 3D echocardiography software. Vena contracta area (VCA) at 6-month follow-up was used to define two outcome groups: patients with good results with VCA < 0.6 cm2 (MR < 0.6) and those with MR recurrence with VCA ≥ 0.6 cm2 (MR ≥ 0.6). MR recurrence was found in 34% of all study patients (21 of 61). In patients with FMR, significant differences between MR < 0.6 and MR ≥ 0.6 were found at baseline for tenting index (1.13 vs 1.23, P = .004), tenting volume (2.8 vs 4.0 ml, P = .04), indexed left ventricular (LV) end-diastolic volume (68.0 vs 99.9 ml/m2, P = .001), and VCA (0.71 vs 1.00 cm2, P = .003); no significant parameters of MR recurrence were found in patients with OMR. Multivariate analysis identified indexed LV end-diastolic volume as the strongest independent determinant of MR recurrence. Receiver operating characteristic analysis identified a tenting index of 1.185 (area under the curve 0.79) and indexed LV end-diastolic volume of 88 ml/m2 (area under the curve 0.76) to best discriminate between MR < 0.6 and MR ≥ 0.6. MR recurrence after TMVR in patients with FMR is associated with advanced LV dilation and MV tenting before TMVR, which provides clinical implications for a point of no return beyond which progressive LV dilation with MV geometry dilation and tethering cannot be effectively prevented by TMVR. In contrast, no significant determinants of MR recurrence and progressive MV annular dilation could be identified in patients with OMR." @default.
- W3137669883 created "2021-03-29" @default.
- W3137669883 creator A5001208213 @default.
- W3137669883 creator A5014450228 @default.
- W3137669883 creator A5018502590 @default.
- W3137669883 creator A5041896635 @default.
- W3137669883 creator A5060685811 @default.
- W3137669883 creator A5070627801 @default.
- W3137669883 creator A5086319781 @default.
- W3137669883 date "2021-07-01" @default.
- W3137669883 modified "2023-10-17" @default.
- W3137669883 title "Recurrence of Functional Versus Organic Mitral Regurgitation After Transcatheter Mitral Valve Repair: Implications from Three-Dimensional Echocardiographic Analysis of Mitral Valve Geometry and Left Ventricular Dilation for a Point of No Return" @default.
- W3137669883 cites W1414597353 @default.
- W3137669883 cites W1702900437 @default.
- W3137669883 cites W2000108005 @default.
- W3137669883 cites W203013263 @default.
- W3137669883 cites W2055180480 @default.
- W3137669883 cites W206038815 @default.
- W3137669883 cites W2066679120 @default.
- W3137669883 cites W2079710389 @default.
- W3137669883 cites W2081395468 @default.
- W3137669883 cites W2092723406 @default.
- W3137669883 cites W2092902993 @default.
- W3137669883 cites W2095277607 @default.
- W3137669883 cites W2101825249 @default.
- W3137669883 cites W2102732338 @default.
- W3137669883 cites W2109088822 @default.
- W3137669883 cites W2112323503 @default.
- W3137669883 cites W2118617533 @default.
- W3137669883 cites W2122694177 @default.
- W3137669883 cites W2126375084 @default.
- W3137669883 cites W2146662368 @default.
- W3137669883 cites W2152109453 @default.
- W3137669883 cites W2153219359 @default.
- W3137669883 cites W2163848870 @default.
- W3137669883 cites W2177458713 @default.
- W3137669883 cites W2546721386 @default.
- W3137669883 cites W2548861862 @default.
- W3137669883 cites W2565230122 @default.
- W3137669883 cites W2596797126 @default.
- W3137669883 cites W2608093180 @default.
- W3137669883 cites W2610593164 @default.
- W3137669883 cites W2741940170 @default.
- W3137669883 cites W2755891002 @default.
- W3137669883 cites W2809880592 @default.
- W3137669883 cites W2888290077 @default.
- W3137669883 cites W2889688444 @default.
- W3137669883 cites W2961519708 @default.
- W3137669883 cites W4205993996 @default.
- W3137669883 cites W4292290582 @default.
- W3137669883 doi "https://doi.org/10.1016/j.echo.2021.02.017" @default.
- W3137669883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33722676" @default.
- W3137669883 hasPublicationYear "2021" @default.
- W3137669883 type Work @default.
- W3137669883 sameAs 3137669883 @default.
- W3137669883 citedByCount "5" @default.
- W3137669883 countsByYear W31376698832022 @default.
- W3137669883 countsByYear W31376698832023 @default.
- W3137669883 crossrefType "journal-article" @default.
- W3137669883 hasAuthorship W3137669883A5001208213 @default.
- W3137669883 hasAuthorship W3137669883A5014450228 @default.
- W3137669883 hasAuthorship W3137669883A5018502590 @default.
- W3137669883 hasAuthorship W3137669883A5041896635 @default.
- W3137669883 hasAuthorship W3137669883A5060685811 @default.
- W3137669883 hasAuthorship W3137669883A5070627801 @default.
- W3137669883 hasAuthorship W3137669883A5086319781 @default.
- W3137669883 hasConcept C126322002 @default.
- W3137669883 hasConcept C164705383 @default.
- W3137669883 hasConcept C182536299 @default.
- W3137669883 hasConcept C2777543888 @default.
- W3137669883 hasConcept C2778198053 @default.
- W3137669883 hasConcept C2780793704 @default.
- W3137669883 hasConcept C2909944400 @default.
- W3137669883 hasConcept C2993373945 @default.
- W3137669883 hasConcept C71924100 @default.
- W3137669883 hasConcept C78085059 @default.
- W3137669883 hasConceptScore W3137669883C126322002 @default.
- W3137669883 hasConceptScore W3137669883C164705383 @default.
- W3137669883 hasConceptScore W3137669883C182536299 @default.
- W3137669883 hasConceptScore W3137669883C2777543888 @default.
- W3137669883 hasConceptScore W3137669883C2778198053 @default.
- W3137669883 hasConceptScore W3137669883C2780793704 @default.
- W3137669883 hasConceptScore W3137669883C2909944400 @default.
- W3137669883 hasConceptScore W3137669883C2993373945 @default.
- W3137669883 hasConceptScore W3137669883C71924100 @default.
- W3137669883 hasConceptScore W3137669883C78085059 @default.
- W3137669883 hasIssue "7" @default.
- W3137669883 hasLocation W31376698831 @default.
- W3137669883 hasOpenAccess W3137669883 @default.
- W3137669883 hasPrimaryLocation W31376698831 @default.
- W3137669883 hasRelatedWork W2065829462 @default.
- W3137669883 hasRelatedWork W2762049695 @default.
- W3137669883 hasRelatedWork W2793684859 @default.
- W3137669883 hasRelatedWork W2794456258 @default.
- W3137669883 hasRelatedWork W2889030335 @default.
- W3137669883 hasRelatedWork W2889278515 @default.
- W3137669883 hasRelatedWork W2890366698 @default.
- W3137669883 hasRelatedWork W2936554318 @default.